Xiaoli Mi

620 citations
15 papers · 427 · 1 hit paper · h-index 11

Impact in

  • Hematology top 10%
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
  • Genetics top 10%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 6
    • Chronic Lymphocytic Leukemia Research 3
    • Hemoglobinopathies and Related Disorders 1

Xiaoli Mi

14 papers receiving 418 citations

Xiaoli Mi's Hit Papers

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127 2024 · 113 citations
1130+1Years since publication255075100

Peers

Xiaoli Mi
Comparison fields: 5 of 28
  • Hematology 123
  • Genetics 79
  • Molecular Biology 175
  • Oncology 46
  • Public Health, Environmental and Occupational Health 29
Replace Kristina M. Brumme with:
Kristina M. Brumme United States
Kellie-Marie Banks Australia
A Dufour Germany
Julius Gräsel Australia
Mélanie Pannetier France
Jenny Klintman Sweden
Gina T. Kirsammer United States
Yohan Royer Belgium
Melissa Ann Fischer United States
Connor McGuckin United States
Xiaoli Mi relative to Kristina M. Brumme United States Kristina M. Brumme's profile →
Citations per field
00.5×10×20×25.5×
Kristina M. Brumme · 1×
Citations per year

Countries citing papers authored by Xiaoli Mi

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Mi more than expected).

Fields of papers citing papers by Xiaoli Mi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Mi. The network helps show where Xiaoli Mi may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoli Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoli Mi Line = papers co-authored together Xiaoli Mi links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
Hit paper breakdown →
2024113
2 202050
3 201843
4 202343
5 201932
6 202331
7 201829
8 202520
9 202319
10 202017
11 202214
12 202511
13 20243
14 20202
15 20260

About Xiaoli Mi

Xiaoli Mi is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 15 papers that have together received 427 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), RNA Research and Splicing (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Epigenetics and DNA Methylation (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and Cancer-related gene regulation (1 paper). The work is most often cited by research in Hematology (123 citations), Genetics (79 citations), Molecular Biology (175 citations), Oncology (46 citations) and Public Health, Environmental and Occupational Health (29 citations). Xiaoli Mi has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Omar Ibrahim Abdel-Wahab, Alexander V. Penson, Sham Mailankody, Justin Taylor, Eytan M. Stein, Joseph Pangallo, Wenbin Xiao, Jon Christopher Aster, Andriy Derkach and Jahan A. Rahman. Their work appears in journals such as Blood, Leukemia, American Journal of Hematology, JCO Precision Oncology and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact